2215 Yukon St.
Vancouver BC V5Y 0A1
AbCellera is a privately held biotechnology company with a drug discovery platform that searches and analyzes natural immune systems to find antibodies used to prevent and treat disease. AbCellera’s technology combines high-throughput microfluidics, AI and genomics, and provides in-house access to transgenic mouse and bispecific platforms to identify first-in-class drugs and reduce the time of bringing treatments to the clinic. AbCellera's partners include leading biotechs and top 10 biopharmaceutical companies.